, , ,

Q10 PLUS 90 CAPS

49.06

En stock

FacebookTwitterGoogle Plus

Description

Q10 Plus is een formule die speciaal ontworpen werd om de hartfunctie en de bloedsomloop te ondersteunen. Q10 Plus bevat, naast co-enzym Q10, taurine, Crataegus oxyacantha (tweestijlige meidoorn), magnesium, Ginkgo biloba en Lmethionine. Hartweefsel bevat hoge concentraties aan taurine. De bessen en bloesems van tweestijlige meidoorn worden al sinds eeuwen gebruikt om de hartfunctie te verzorgen. Crateagus oxycantha werkt verkwikkend voor het hart, is gunstig voor de bloedsomloop en houdt de normale bloeddruk in stand. Magnesium is zeer belangrijk voor het in stand houden van de cardiovasculaire gezondheid. Ginkgo biloba optimaliseert zowel de perifere als de arteriële doorbloeding. L-methionine is een lipotroop aminozuur.

1 capsule per dag of zoals aanbevolen

  1. Degenring FH, Suter A, Weber M, Saller R A randomised double blind placebo controlled clinical trial of a standardised extract of fresh
    Crataegus berries (Crataegisan) in the treatment of patients with congestive
    heart failure NYHA II.Phytomedicine. 2003;10(5):363-9.

  2. Schaffer S, Solodushko V, Pastukh V, Ricci C, Azuma J Possible Cause
    of Taurine-deficient Cardiomyopathy: Potentiation of Angiotensin II Action. J
    Cardiovasc Pharmacol. 2003 May;41(5):751-9

  3. Takahashi K, Ohyabu Y, Takahashi K, Solodushko V, Takatani T, Itoh T,
    Schaffer SW, Azuma J. Taurine renders the cell resistant to ischemia-induced
    injury in cultured neonatal rat cardiomyocytes.J Cardiovasc Pharmacol. 2003
    May;41(5):726-33.

  4. Sarter B Coenzyme Q10 and cardiovascular disease: a review. J
    Cardiovasc Nurs. 2002 Jul;16(4):9-20. Review.

  5. Atar D., Mortensen S.A., Flachs H., Herzog W.R. Coenzyme Q10 Protects
    Ischemic Myocardium in an Open-Chest Swine Model. Clin. Investig., 1993, 71
    :S103-S111.

  6. Baggio E., Gandini R., Plancher C., Passeri N., Carmosino G. Italian
    Multi-Centre Study on the Safety and Efficacy of Coenzyme Q10 as Adjuvant
    Therapy in Heart Failure. Clin. Investig., 1993, 71 :S145-S149.

  7. di Palma A., Masini M., Cimatti G., Adamanti S., et al. Coenzyme Q10
    : a probable longevity marker. Biomed. And Clin. Aspects of Q10, 6 :489-
    492, 1991.

  8. Hanaki Y., Sugiyama S., Ozawa T., Ohno M. Coenzyme Q10 and Coronary
    Artery Disease. Clin. Investig., 1993, 71 :S112- S115.

  9. Judy W.V., Stogsdill W.W., Folkers K. Myocardial Preservation by
    Therapy With Coenzyme Q10 During Heart Surgery. Clin. Investig., 1993, 71
    :S155-S161.

  10. Kamei M., Fujita T., Kanbe T., Saski K., et al. The distribution and
    content of ubiquinone in foods. Int. J. Vitam. Nutr. Res., 56 :1 :57-63,

  11. Kuklinski B., von Appen S., Weissenbacher E. Coenzyme Q10 and
    Antioxidants in Acute Myocardial Infarction. 8th Int. Symp. Biomed. and
    Cln. Aspects of CoQ10, 1993, s. 32.

  12. Mordente A., Martorana G.E., Santini S.A., Miggiano G.A.D.
    Antioxidant Effect of Coenzyme Q10 on Hydrogen Peroxide-activated Myoglobin.
    Clin. Investig., 1993, 71 :S92-S96.

  13. Morisco C., Trimarco B., Condorelli M. Effect of Coenzyme Q10 Therapy
    in Patients with Congestive Heart Failure : A Long Term Multi-Centre
    Randomized Study. Clin. Investig., 1993, 71 :S134- S136.

  14. Mortensen S.A., Vadhanavikit S., Muratsu K., Folkers K. CoQ10 :
    Clinical benefits with biochem. Correlates suggesting a break through in the
    management of chronic heart failure. Int. J. Tiss. Reac. : 12 :3 :155-162,

  15. Sugimoto M., Ideta T., Imanishi K., Ono T., et al. Effect of CoQ10 in
    patients with progressive muscular dystrophy and other neuromuscular
    diseases. Biomed. and Clin. Aspects of CoQ10. 1 :243-250, 1984.

  16. Wilkinson E.G., Arnold R.M., Folkers K. Treatment of periodontal and
    other soft tissue diseases of the oral cavity with coenzyme Q. Biomed. and
    Clin. Aspects of CoQ10, 1 :251 :266, 1977.

  17. Yamagami T., Takagi M., Akagami H., Folkers K. Effect on Q10 on
    essential hypertension, a double blind controlled study. Biomed. and Clin.
    Aspects of CoQ10. 5 :337-344, 1986.

  18. Zeppilli P., Merlino B., de Luca A., Littaru G.P., et al. Influence
    of CoQ10 on physical work capacity of athletes, sedentary people and patients
    with mitochondrial disease. Biomed. and Clin. Aspects of Q10.

Niet te gebruiken bij: geen gevallen gekend.

INGREDIENTEN PER CAPSULE
Taurine 300 mg
Tweestijlige meidoorn (Crataegus oxyacantha) 100 mg
Magnesiumcitraat 80 mg
Kaliumcitraat 30 mg
Ginkgo biloba-extract (24% conc.) 20 mg
Co-enzym Q10 (ubiquinon) 10 mg
L-methionine 250 µg
Hulpstoffen: gelatine, microkristallijne cellulose, magnesiumstearaat
*%RI = Referentie Inname (E.C.)

Informations complémentaires

Marque